empty
 
 
rs
Search
Podrška
Trenutno otvaranje računa
Trgovačka platforma
Depozit/Povlačenje
Search
Za početnike Za trgovce Za partnere Idi na pauzu About InstaSpot
rs
#AMGN Nazad na listu instrumenata #AZN

Menjač valuta

Aurinia Pharmaceuticals Inc
15.78 USD
12 Dec 2025 22:59
Promena cene (% chg)
$0.01
(0.06%)
Cena prethodnog zatvaranja
Cena prethodnog zatvaranja

Cena zatvaranja prethodnog dana.
$15.81
Otvaranje
Otvaranje

Cena na otvaranju.
$15.47
Dnevni maksimum
Dnevni maksimum

Najviša cena tokom poslednjeg dana trgovine.
$15.92
Dnevni minimum
Dnevni minimum

Najniža cena tokom poslednjeg dana trgovine
$15.65
Maksimum u 52 nedelje
Maksimum u 52 nedelje

Opseg najviših cena u poslednje 52 nedelje
$15.92
Minimum u 52 nedelje
Minimum u 52 nedelje

Opseg najnižinih cena u poslednje 52 nedelje
$14.75
Preuzmi arhivu
Buy
15.78
Sell
15.78
Otvori grafikon za pregled na celom ekranu
Buy
15.78
Sell
15.78
Preuzmi arhivu
Otvori grafikon za pregled na celom ekranu

About Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. is a Canadian biotech company specializing in the production of drugs against autoimmune diseases.

Aurinia Pharmaceuticals Inc. maintains cooperation with Japanese companies, particularly Otsuka Pharmaceutical Co.

The company’s market cap currently stands at $1.067 billion. Aurinia reported revenues of $45.6 million last year with a net loss of $180.97 million.

Aurinia Pharmaceuticals Inc. stock and what affects it

The stock is traded on the NASDAQ exchange under the ticker name of AUPH. There is no information about upcoming dividend payments.

The stock is currently trading between $7.4 and $7.7. Over the past year, the share price has fluctuated from $6.29 to $33.97.

When trading this asset, you should pay attention to the following:

  • Any negative events and news will be detrimental to the company.
  • The company's earnings strongly depend on the results of new product trials.
  • It is not recommended to allocate more than 5% of your investment portfolio to this stock.
  • This is a high-risk stock with fairly large returns of over 30%.

Ne možete da razgovarate sada?
Postavite pitanje kroz ćaskanje.